Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reactogenicity of Tdap/Tdap-IPV Booster in Adolescents
NCT00304265Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2006
- Primary completion
- Oct 2006
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 4, open-label trial of Adacel Polio and COVAXIN in pertussis, diphtheria, Tetanus and 1 more (2 arms), sponsored by Sanofi. Primary endpoint: Number of Participants Reporting a Solicited Local or Systemic Reaction Post-Vaccination at 14 days. Started Mar 2006; status: completed.
02
Drugs
Adacel PolioCOVAXIN
03
Conditions
pertussisdiphtheriaTetanuspoliomyelitis
Beyond the preview
Go deeper on NCT00304265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304265.